The Consumer Electronics Show (CES) 2025 in Las Vegas has become a prominent platform for showcasing cutting-edge health and wellness technologies. Among the vast array of innovations presented this year, several European startups are drawing attention for their pioneering approaches to improving healthcare delivery and personal well-being. These innovations aim to address critical issues such as medication adherence, accessibility of care, and pain relief, promising to reshape how health technologies are integrated into daily life.
What makes FlowBeams’ needle-free injections unique?
FlowBeams, a Netherlands-based company, has introduced a needle-free injection technology that employs laser-generated bubbles to deliver medication through the skin. The process is nearly painless, reducing the risk of needle-related injuries and phobias. By ensuring precise delivery at a specific skin depth, this method enhances the efficacy of treatments like vaccines and insulin while also minimizing biohazard waste. The company envisions applications across the pharmaceutical and cosmetics sectors.
Can technology redefine at-home health monitoring?
Yes, startups like Dose from the UK and Clementine from the Netherlands are leading the charge. Dose has developed a smart transdermal patch system for precise medication dosing and remote pain relief approval. Meanwhile, Clementine Home enables individuals to perform hearing screenings and otoscope assessments at home, targeting the 1.5 billion people with hearing loss. By increasing accessibility and reducing stigma, these tools encourage a more proactive approach to personal health management.
Calopad, a Swiss innovation, offers a reusable deep heat plaster for localized pain relief and muscle recovery. Its companion app enhances the therapy experience by providing tailored physiotherapy exercises. Similarly, StethoMe from Poland has created an AI-powered stethoscope that detects abnormal respiratory sounds with high accuracy. These developments emphasize the shift towards personalized, at-home healthcare solutions.
LAIKA, an Italian AI platform, supports veterinarians by streamlining clinical workflows and analyzing diagnostic data. It assists in everything from patient history collection to differential diagnoses, helping reduce stress among veterinary professionals. Lastly, Vivoo, originating from Turkey and the US, has taken its urine-testing innovation a step further with a “smart toilet” attachment. This device evaluates hydration levels and aims to cater to both businesses and home users by 2026.
Health tech innovations from previous CES events have demonstrated consistent efforts to address pain points in healthcare, such as accessibility and diagnostic accuracy. However, this year’s focus on user-centric, data-driven tools and sustainability marks a notable evolution in the sector, reflecting the growing emphasis on personalized and environmentally conscious solutions.
The showcased technologies highlight the convergence of artificial intelligence, precision engineering, and healthcare expertise to provide more efficient and accessible solutions. For example, FlowBeams’ needle-free injections could find widespread applications in low-resource areas, while Clementine’s hearing assessment tool helps tackle global health inequities. As these innovations move closer to commercial availability, they promise to make healthcare more personalized, efficient, and sustainable.
The insights gained from these technologies underscore the role of CES as a vital platform for accelerating health-tech advancements. By addressing diverse challenges, from medication adherence to veterinary diagnostics, these European startups contribute to reshaping health systems and empowering users to take greater control of their well-being. As these solutions reach broader markets, their impact is likely to extend beyond individual care to systemic healthcare improvements.
